bioRxivCancer BiologyPreprint
Peculiar cases of a \"sleeping\" brain in alert cancer patients
H. Benveniste, P. Vaska, D. Franceschi, M. Salerno, S. Rizwan, H. Lee, J. Logan, D. Rothman, Y. Lazebnik, N. D. Volkow, T. V. Bilfinger
Abstract
Cognitive and constitutional symptomatology is common in cancer patients but the causes are not well understood. To investigate whether cancers cause these symptoms by changing cerebral metabolism, we measured the cerebral rate of glucose consumption (CMRglc) in patients diagnosed with a lung lesion.\n\nMethodsThe CMRglc was quantified in 20 patients undergoing 18F-FDG PET for lesion staging. The cognitive status was assessed by neuropsychological testing.\n\nResultsParadoxically, despite being alert three of the patients had CMRglc typical of people who are in deep sleep or anesthetized. All three had cancers, two died within 2 months of scanning. Remaining patients including four with early stage cancer had CMRglc within normal range.\n\nConclusionsWe speculate that the low CMRglc reflects a switch to an alternative energy source that is mediated by cancers remotely. Identifying the underlying mechanism and the alternative energy sources may help to understand how cancers can change body metabolism.
- organism: human
- assay: imaging
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Hyperglycemia and Cancer. Human lung carcinoma by means of Raman spectroscopy and imaging
H. Abramczyk, M. Kopec, K. Beton·bioRxiv·Apr 5, 2022
- PET by MRI: Glucose Imaging by 13C-MRS without Dynamic Nuclear Polarization by Noise Suppression through Tensor Decomposition Rank Reduction
Jeffrey R. Brender, Shun Kishimoto, … Murali C. Krishna·bioRxiv·Feb 15, 2018
- Revision of commonly accepted Warburg mechanism of cancer development. Redox-sensitive mitochondrial cytochromes in breast and brain cancers by Raman imaging
H. Abramczyk, J. Surmacki, … M. Kopec·bioRxiv·Feb 3, 2021
- Distinguishing Closely Related Pancreatic Cancer Subtypes In Vivo by 13C Glucose MRI without Hyperpolarization
S. Kishimoto, J. R. Brender, … M. C. Krishna·bioRxiv·Jan 4, 2019
- GlucoCEST MRI for the early evaluation response to chemotherapeutic and metabolic treatments in a murine triple negative breast cancer: a comparison with 18F-FDG-PET.
M. Capozza, A. A. Anemone, … S. Aime·bioRxiv·Mar 16, 2021
- Flux estimation analysis systematically characterizes the metabolic shifts of the central metabolism pathway in human cancer.
Grace Meijuan Yang, Shaoyang Huang, … Chi Zhang·Frontiers in OncologyPeer-reviewed·Jun 12, 2023